Both in Pharmaceuticals
Alkermes vs Arrowhead Research
Over the past year ALKS returned +54.2% and ARWR returned +51.9%; their daily moves had a correlation of 0.27.
ALKS +54.2% ARWR +51.9%Growth of $1, one year, split-adjusted
| Metric | ALKS | ARWR |
|---|---|---|
| Price | $46.52 | $60.15 |
| Market cap | $7.80B | $8.50B |
| Today | +3.63% | +0.97% |
| 1 month | +8.8% | −3.5% |
| 6 months | +28.3% | −19.7% |
| Year to date | +66.3% | −9.4% |
| 1 year | +51.5% | +41.9% |
| Revenue growth (YoY) | +27.0% | +171.0% |
| Gross margin | 80.2% | 100.0% |
| Net margin | 0.1% | −258.2% |
| P/E (TTM) | 118.0× | — |
| Price / sales | 4.7× | 12.7× |
| Net cash | -$846.5M | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 32.4% | 45.2% |
| Short % of float | 11.5% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).